BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9712786)

  • 1. Immunization against natural Helicobacter pylori infection in nonhuman primates.
    Dubois A; Lee CK; Fiala N; Kleanthous H; Mehlman PT; Monath T
    Infect Immun; 1998 Sep; 66(9):4340-6. PubMed ID: 9712786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of rhesus monkeys.
    Lee CK; Soike K; Hill J; Georgakopoulos K; Tibbitts T; Ingrassia J; Gray H; Boden J; Kleanthous H; Giannasca P; Ermak T; Weltzin R; Blanchard J; Monath TP
    Vaccine; 1999 Mar; 17(11-12):1493-505. PubMed ID: 10195786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral immunization with recombinant Helicobacter pylori urease confers long-lasting immunity against Helicobacter felis infection.
    Myers GA; Ermak TH; Georgakopoulos K; Tibbitts T; Ingrassia J; Gray H; Kleanthous H; Lee CK; Monath TP
    Vaccine; 1999 Mar; 17(11-12):1394-403. PubMed ID: 10195775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection.
    Weltzin R; Guy B; Thomas WD; Giannasca PJ; Monath TP
    Infect Immun; 2000 May; 68(5):2775-82. PubMed ID: 10768972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults.
    Michetti P; Kreiss C; Kotloff KL; Porta N; Blanco JL; Bachmann D; Herranz M; Saldinger PF; Corthésy-Theulaz I; Losonsky G; Nichols R; Simon J; Stolte M; Ackerman S; Monath TP; Blum AL
    Gastroenterology; 1999 Apr; 116(4):804-12. PubMed ID: 10092302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection.
    Kotloff KL; Sztein MB; Wasserman SS; Losonsky GA; DiLorenzo SC; Walker RI
    Infect Immun; 2001 Jun; 69(6):3581-90. PubMed ID: 11349017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization of rhesus monkeys with a mucosal prime, parenteral boost strategy protects against infection with Helicobacter pylori.
    Lee CK; Soike K; Giannasca P; Hill J; Weltzin R; Kleanthous H; Blanchard J; Monath TP
    Vaccine; 1999 Aug; 17(23-24):3072-82. PubMed ID: 10462242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double mutant heat-labile toxin from Escherichia coli, LT(R192G/L211A), is an effective mucosal adjuvant for vaccination against Helicobacter pylori infection.
    Sjökvist Ottsjö L; Flach CF; Clements J; Holmgren J; Raghavan S
    Infect Immun; 2013 May; 81(5):1532-40. PubMed ID: 23439305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection.
    Kleanthous H; Myers GA; Georgakopoulos KM; Tibbitts TJ; Ingrassia JW; Gray HL; Ding R; Zhang ZZ; Lei W; Nichols R; Lee CK; Ermak TH; Monath TP
    Infect Immun; 1998 Jun; 66(6):2879-86. PubMed ID: 9596763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant.
    Marchetti M; Rossi M; Giannelli V; Giuliani MM; Pizza M; Censini S; Covacci A; Massari P; Pagliaccia C; Manetti R; Telford JL; Douce G; Dougan G; Rappuoli R; Ghiara P
    Vaccine; 1998 Jan; 16(1):33-7. PubMed ID: 9607006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with recombinant Helicobacter pylori urease in specific-pathogen-free rhesus monkeys (Macaca mulatta).
    Solnick JV; Canfield DR; Hansen LM; Torabian SZ
    Infect Immun; 2000 May; 68(5):2560-5. PubMed ID: 10768944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses.
    Ermak TH; Giannasca PJ; Nichols R; Myers GA; Nedrud J; Weltzin R; Lee CK; Kleanthous H; Monath TP
    J Exp Med; 1998 Dec; 188(12):2277-88. PubMed ID: 9858514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infection.
    Weltzin R; Kleanthous H; Guirakhoo F; Monath TP; Lee CK
    Vaccine; 1997 Mar; 15(4):370-6. PubMed ID: 9141207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of E coli enterotoxin adjuvant for urease-based rectal immunization against Helicobacter pylori.
    Sougioultzis S; Lee CK; Alsahli M; Banerjee S; Cadoz M; Schrader R; Guy B; Bedford P; Monath TP; Kelly CP; Michetti P
    Vaccine; 2002 Dec; 21(3-4):194-201. PubMed ID: 12450694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of vaccination by a recombinant antigen ureB138 (a segment of the beta-subunit of urease) against Helicobacter pylori infection.
    Morihara F; Fujii R; Hifumi E; Nishizono A; Uda T
    J Med Microbiol; 2007 Jun; 56(Pt 6):847-853. PubMed ID: 17510273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination against Helicobacter pylori in non-human primate models and humans.
    Lee CK
    Scand J Immunol; 2001 May; 53(5):437-42. PubMed ID: 11309150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward the development of a stable, freeze-dried formulation of Helicobacter pylori killed whole cell vaccine adjuvanted with a novel mutant of Escherichia coli heat-labile toxin.
    Summerton NA; Welch RW; Bondoc L; Yang HH; Pleune B; Ramachandran N; Harris AM; Bland D; Jackson WJ; Park S; Clements JD; Nabors GS
    Vaccine; 2010 Feb; 28(5):1404-11. PubMed ID: 19897067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on
    Guo L; Yang H; Tang F; Yin R; Liu H; Gong X; Wei J; Zhang Y; Xu G; Liu K
    Front Cell Infect Microbiol; 2017; 7():349. PubMed ID: 28824883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis.
    Lee CK; Weltzin R; Thomas WD; Kleanthous H; Ermak TH; Soman G; Hill JE; Ackerman SK; Monath TP
    J Infect Dis; 1995 Jul; 172(1):161-72. PubMed ID: 7797906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy of a multi-epitope vaccine against Helicobacter pylori infection in BALB/c mice model.
    Zhou WY; Shi Y; Wu C; Zhang WJ; Mao XH; Guo G; Li HX; Zou QM
    Vaccine; 2009 Aug; 27(36):5013-9. PubMed ID: 19446591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.